These findings are particularly in line a prior study, wherein DNMT3A and DNMT3B were illustrated to repress E-cadherin expression by methylation of the E-cadherin promoter, while down-regulation of E-cadherin was associated with deterioration of DNMT3B in hospitalized breast cancer patients [28]. Here, CDH1 is linked to breast carcinoma.